Novartis AG
PROCESS FOR CONCENTRATION OF ANTIBODIES AND THERAPEUTIC PRODUCTS THEREOF

Last updated:

Abstract:

The present disclosure provides a process for concentrating proteins including an ultrafiltering, a diafiltering, and a second ultrafiltering sequence, at elevated temperatures, such as above about 30.degree. C. The disclosure also includes a process for preparing highly concentrated antibody compositions, and highly concentrated antibody products.

Status:
Application
Type:

Utility

Filling date:

10 Sep 2020

Issue date:

1 Apr 2021